Fortress Biotech (FBIO) Shares Outstanding (Entity) (2010 - 2026)
Analysis
Fortress Biotech (FBIO) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | 399.00 Mn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | 214.24 Mn |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 113.02 Mn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 133.73 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 575.00 Mn |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 218.28 Mn |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn | 33.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.31 Mn |
| Dec 31, 2025 | 31.36 Mn |
| Sep 30, 2025 | 31.01 Mn |
| Jun 30, 2025 | 29.75 Mn |
| Mar 31, 2025 | 29.55 Mn |
| Dec 31, 2024 | 32.96 Mn |
| Sep 30, 2024 | 31.03 Mn |
| Jun 30, 2024 | 26.24 Mn |
| Mar 31, 2024 | 23.34 Mn |
| Dec 31, 2023 | 22.66 Mn |
| Sep 30, 2023 | 12.37 Mn |
| Jun 30, 2023 | 8.78 Mn |
| Mar 31, 2023 | 9.18 Mn |
| Dec 31, 2022 | 8.88 Mn |
| Sep 30, 2022 | 7.47 Mn |
| Jun 30, 2022 | 7.41 Mn |
| Mar 31, 2022 | 7.39 Mn |
| Dec 31, 2021 | 7.20 Mn |
| Sep 30, 2021 | 6.87 Mn |
| Jun 30, 2021 | 6.73 Mn |